冠状动脉慢性完全闭塞病变介入治疗的进展  

Recent advances in percutaneous coronary intervention for chronic total occlusion of coronary artery

作　　者：曾秋棠[1] 彭昱东 ZENG Qiutang;PENG Yudong(Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院心内科,武汉430022

出　　处：《临床心血管病杂志》2024年第5期351-354,共4页Journal of Clinical Cardiology

摘　　要：冠状动脉慢性完全闭塞(CTO)病变在经皮冠状动脉介入治疗(PCI)患者中非常普遍,其手术难度大,风险高,目前的临床终点获益尚不明确。本文总结了CTO-PCI随机对照临床试验和观察性研究,介绍了近些年最新的PCI器械和管理策略,以期为CTO-PCI提供全新的理论和实践依据。Chronic total occlusion(CTO)of the coronary artery is a common occurrence among patients undergoing percutaneous coronary intervention(PCI),a procedure known for its difficulty and associated risks.However,the precise clinical endpoint benefit of CTO-PCI remains unclear.In this review,we aim to provide a comprehensive summary of recent randomized controlled clinical trials(RCTs)and observational studies pertaining to CTO-PCI.Additionally,we introduced the latest PCI devices and management strategies developed in recent years.By consolidating existing evidence and advancements,this review seeks to offer a new theoretical and practical foundation for enhancing CTO-PCI procedures and outcomes.

关 键 词：冠状动脉粥样硬化 闭塞病变 介入治疗 

分 类 号：R541.4[医药卫生—心血管疾病]